Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Teladoc reports after market close, meaning Day 0 reflects pre-earnings anticipation while Day +1 captures the market's first full reaction to results.

Historical price action reveals significant volatility around Teladoc earnings, with the stock averaging an 8.88% absolute move on Day +1 following results. The most dramatic reaction came after July 2026 earnings, when shares plunged -28.32% the day after reporting—likely reflecting the BetterHelp guidance cut and insurance transition concerns. Beyond that outlier, Day +1 moves have ranged from -13.56% (February 2025) to +15.05% (February 2026), demonstrating the stock's tendency to make substantial directional moves as investors digest results.

Day 0 moves are more muted, averaging 2.40%, which is typical for after-hours reporters where initial reactions occur in lower-volume extended trading. The 13.07% average Day +1 range underscores the stock's high beta (2.13) and the market's uncertainty about the company's turnaround trajectory. Investors should prepare for potential double-digit percentage swings in either direction following this release.

Part 2.2: Options Market Expected Move

The options market is pricing a 10.02% expected move through the October 30 expiration, implying a range of $5.80 to $7.10. This sits slightly above the 8.88% average Day +1 move from recent earnings history, suggesting options traders are pricing in elevated uncertainty—likely reflecting concerns about BetterHelp's performance and whether management can deliver on reaffirmed guidance. The premium over historical averages indicates the market expects this quarter could produce another outsized reaction similar to recent volatile prints.

Part 3: What Analysts Are Saying

Analyst sentiment on Teladoc remains cautious, with the consensus rating at 3.56 (Hold) based on 25 analysts. The breakdown shows 7 Strong Buys, 0 Moderate Buys, 18 Holds, 0 Moderate Sells, and 0 Strong Sells—a distribution that reflects skepticism about near-term catalysts but no outright bearishness. The average price target of $7.55 implies 17.05% upside from the current price of $6.45, with estimates ranging from a low of $5.50 to a high of $10.50.

Sentiment has remained unchanged over the past month, with the same 3.56 rating and identical distribution of recommendations. This stability suggests analysts are in wait-and-see mode, looking for evidence that the BetterHelp insurance transition is progressing and that Integrated Care can sustain its outperformance. The wide spread between the high and low price targets ($5.00 range) reflects divergent views on whether Teladoc can successfully navigate its current challenges or faces further multiple compression if execution falters.

Part 4: Technical Picture

Teladoc's technical setup heading into earnings shows improving short-term momentum but remains under pressure from longer-term resistance. The Barchart Technical Opinion currently reads 32% Sell, representing a notable improvement from 48% Sell one week ago and 56% Sell one month ago. This strengthening signal reflects the stock's recent bounce off its 52-week low of $4.40 and climb above multiple short-term moving averages.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal suggests near-term momentum remains tentative despite recent gains
• Medium-term (50% Sell): Neutral-to-negative reading indicates consolidation with downside bias in the intermediate timeframe
• Long-term (25% Sell): Weaker sell signal reflects some stabilization in the longer-term trend after the severe July selloff

Trend Characteristics: The Weak strength combined with Weakest direction indicates a fragile technical environment where the stock remains vulnerable to renewed selling pressure despite recent stabilization.

The stock is currently trading above its 5-day ($6.33), 10-day ($6.10), 20-day ($5.92), 50-day ($6.14), and 200-day ($6.45) moving averages, but remains below its 100-day average ($7.11)—a key resistance level that marks the dividing line between recovery and continued weakness.

The technical picture presents a mixed setup for earnings. While TDOC has reclaimed its 200-day moving average and built a cushion above short-term support levels, the stock remains well below its 100-day average and mid-year highs near $9.89. The 52-week range of $4.40 to $9.89 illustrates the dramatic volatility, with current levels closer to the bottom than the top. The improving Barchart Opinion signal and position above the 200-day average provide some technical support, but the weak trend characteristics and proximity to recent lows suggest limited margin for disappointment. A strong earnings beat with credible BetterHelp stabilization could trigger a breakout above the $7.11 resistance, while any guidance concerns risk a retest of the $5.80 support implied by the options market.